Cardiovascular disease supplements refer to nutritional products designed to complement traditional approaches in managing cardiovascular health. These supplements typically contain a variety of vitamins, minerals, antioxidants, and other bioactive compounds that are believed to support heart health. Common cardiovascular disease supplements include omega-3 fatty acids, coenzyme Q10 (CoQ10), magnesium, vitamin D, and various antioxidants such as vitamin C and E. Omega-3 fatty acids, found in fish oil supplements, are often associated with reducing triglycerides and inflammation, while CoQ10 plays a role in cellular energy production. These supplements are commonly taken by individuals aiming to enhance their cardiovascular health, either as part of preventive measures or in conjunction with prescribed medications. It's crucial for individuals considering cardiovascular disease supplements to consult with healthcare professionals, as the effectiveness and safety of these supplements may vary, and potential interactions with medications should be carefully evaluated.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt